𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical pharmacology and the provision of drug information

✍ Scribed by B. Öhman; H. Lyrvall; E. Törnqvist; G. Alván; F. Sjöqvist


Book ID
104692246
Publisher
Springer
Year
1992
Tongue
English
Weight
511 KB
Volume
42
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


Clinical pharmacologists have a service role in the provision of drug information to individuals both in hospitals and primary health care. We present here a systematic approach in answering questions in a drug information centre (DIC), and describe the working method and the documentation of the work in a question answer (Q/A) data base. Drugline is a full-text data base offering problem-oriented drug evaluation comparable to a clinical consultation. The drug information is produced in a non-commercial drug information centre sponsored by the national health care sector and the National Corporation of Swedish Pharmacies, and run jointly by clinical pharmacologists and pharmacists. A minor part of Drugline is available in English for online searching, in parallel with Medline at the database host, the Medical Information Centre at the Karolinska Institute Library and Information Centre, and the users represent mainly medical libraries, hospital pharmacies, university clinics, and the pharmaceutical industry. A network of DICs has been organized in Swedish university hospitals with access to Drugline for searching and the storage of questions and answers. This network has the potential for expansion throughout Europe. It offers the unique possibility of complementing drug product information with problem-oriented drug information emerging from cases in the real world of prescribing.


📜 SIMILAR VOLUMES


Clinical pharmacology and drug safety: L
✍ Conrad, Kenneth A. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 392 KB

The challenge of developing safe and effective drugs has been exemplified recently by reports of phase III studies that have failed to show drug efficacy or have shown excess adverse events. These reports have caused concern in the biomedical and investment communities regarding the ability of the i